The M&A process can be seen as a litmus test for the health of the executive and non-executive team.
Criticaleye asks Liz Claydon, Simon Denham, Bob Emmins, Mark Garrett, Terry Stannard, Paul Staples, Anne Stevens and Jim Wilkinson why NEDs must challenge whether shareholder value is being created.
Share this with your Community
Read, watch & listen to some of the latest thought leadership from our Community.
Displaying 1 to 3 of 448
We use cookies to improve your experience. By using our site, you agree to our use of cookies.